Debbie Ryan
About Debbie Ryan
Debbie Ryan is a Director of Medical Strategy currently working at Bristol Myers Squibb and Mirati Therapeutics. She has extensive experience in the pharmaceutical industry, having held various roles at AstraZeneca and Boehringer Ingelheim over a career spanning more than two decades.
Current Role at Mirati Therapeutics
Debbie Ryan serves as the Director of Medical Strategy at Mirati Therapeutics. She has held this position since 2022 and operates from Chicago, Illinois. In her role, she is responsible for developing and implementing medical strategies that align with the company's objectives in oncology. Her experience in the pharmaceutical industry contributes to her effectiveness in this position.
Previous Experience at AstraZeneca
Debbie Ryan has extensive experience at AstraZeneca, where she worked in various roles over a span of 14 years. She served as Medical Director for 5 months in 2022, and prior to that, she held the position of Director of Medical Diagnostics in US Oncology Medical Affairs from 2020 to 2022. Additionally, she worked as an Executive Oncology Medical Science Liaison from 2015 to 2020 and as a Medical Science Liaison/Product Development Scientist from 1998 to 2010.
Experience at Boehringer Ingelheim
Before her tenure at AstraZeneca, Debbie Ryan worked at Boehringer Ingelheim as a Senior Medical Science Liaison in Oncology from 2010 to 2014. In this role, she focused on providing scientific support and strategic insights to enhance the company's oncology portfolio.
Educational Background
Debbie Ryan studied at Trinity University and North Carolina State University. Her educational background has equipped her with the knowledge and skills necessary for her roles in the pharmaceutical industry, particularly in medical strategy and oncology.